The study was approved by Clarian Health's Institutional Review Board and Research Compliance Administration and was conducted between January 2002 and December 2006. The nomograms were used ...
After the smart infusion technology was implemented, we sought to determine if the system averted errors involving infusions of heparin, a high-risk, commonly used agent. Transaction data obtained ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced in the United States two new presentations of Heparin Sodium in convenient, ready-to-administer Freeflex ® IV bags.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results